Actuate Therapeutics, Inc. (ACTU)
Nasdaq: ACTU · Pharmaceutical Preparations · Fort Worth, TX · filing with the SEC since 2015
Income statement, as filed
In US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 |
| Report filed | Mar 26, 2026 | Mar 13, 2025 | · |
| Research and development | 10,292,620 | 18,676,276 | 21,708,332 |
| General and administrative | 12,202,692 | 6,484,458 | 3,265,497 |
| Total operating expenses | 22,495,312 | 25,160,734 | 24,973,829 |
| Operating income | -22,495,312 | -25,160,734 | -24,973,829 |
| Interest expense | 20,250 | 18,717 | 43,641 |
| Interest and investment income | 287,710 | 222,293 | 352,672 |
| Total non-operating income (expense) | 267,460 | -2,124,594 | 229,209 |
| Income tax expense | 800 | 800 | 0 |
| Net income | -22,227,852 | -27,285,328 | -24,744,620 |
| Earnings per share, basic | -1.06 | -3.26 | -17.24 |
| Earnings per share, diluted | -1.06 | -3.26 | -17.24 |
| Weighted average shares, basic | 21,021,817 | 8,372,741 | 1,434,964 |
| Weighted average shares, diluted | 21,021,817 | 8,372,741 | 1,434,964 |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Research and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseGeneral and administrative the cost of running the company itself
us-gaap:GeneralAndAdministrativeExpenseTotal operating expenses the running costs together
us-gaap:OperatingExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossInterest expense what its borrowing cost
us-gaap:InterestExpenseNonoperatingInterest and investment income what its cash and investments earned
us-gaap:InvestmentIncomeInterestTotal non-operating income (expense) everything outside the business, together
us-gaap:NonoperatingIncomeExpenseIncome tax expense tax charged on the period's profit
us-gaap:IncomeTaxExpenseBenefitNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding